Cerebral palsy is a neurological condition that affects thousands of babies born every year. Damage or malformation of the brain during development, most often in the womb, leads to motor and muscle symptoms. Children with cerebral palsy face a lifelong disability with consequences ranging from being wheelchair bound to painful, tight muscles and joints and even hearing loss, vision loss, cognitive deficits, and many more symptoms and complications that vary by individual. [Read more…]
Interview with the CEO of WideCells: Unlocking the Future of Cord Blood
CellPlan is a revolutionary stem cell insurance product launched by WideCells Group in Manchester, UK. WideCells Group aims to provide people with access to affordable stem cell treatments. In this interview, CEO Joao Andrade describes how the company will facilitate the therapeutic use of umbilical cord blood stem cells by providing worldwide access to stem cell specialists and hospitals.
In this article:
Top 10 Quotes from the Perinatal Stem Cell Society Conference
Over the past three days, dozens of world renowned speakers have presented their latest findings at the Perinatal Stem Cell Society Conference, hosted by Kyle Cetrulo of Auxocell Laboratories and the Perinatal Stem Cell Society (IPLASS).
To capture the best moments from the conference, below are the top 10 quotes from the event, which was hosted at Aspen Meadows Resort in Aspen, CO,.
I took the image above as we were landing in Aspen. You can see our full photo album from the event on Flickr, featuring presenters, sponsors, and more. To get live updates from the event, connect with me on Twitter (@StemCellMarket) or follow the hashtag #Perinatal. Enjoy! [Read more…]
CBR Announces New Pediatric Genetic Screening Test in Collaboration with Sema4
Sema4 collaborated with CBR to launch ReadyGen™, a genetic screening test that analyzes a child’s DNA for 200+ conditions.
LOS ANGELES, Nov. 15, 2019 — CBR, the global leader in newborn stem cell banking, has announced a new genetic service developed over the past couple of years as part of a strategic alliance with Sema4. As a patient-centered health intelligence company and leading innovator within the genomic testing industry, Sema4 collaborated with CBR to launch ReadyGen™, a highly accurate genetic screening test that analyzes a child’s DNA for more than 200 conditions that can affect children before the age of 10. [Read more…]
CBR to Acquire Natera’s Evercord™ Cord Blood Business for an Undisclosed Sum
Cord Blood Registry (CBR), a California Cryobank Life Sciences company, has announced it will acquire Natera’s Evercord™ cord blood business for an undisclosed sum. CBR is the largest newborn stem cell collection and storage company within the United States with more than 875,000 stem cell samples in storage. Natera is a publicly listed company (NASDAQ: NTRA) that specializes in genetic testing services. [Read more…]
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 31
- Next Page »